BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 22147810)

  • 1. Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.
    Di Iorio CR; Watkins TJ; Dietrich MS; Cao A; Blackford JU; Rogers B; Ansari MS; Baldwin RM; Li R; Kessler RM; Salomon RM; Benningfield M; Cowan RL
    Arch Gen Psychiatry; 2012 Apr; 69(4):399-409. PubMed ID: 22147810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
    Erritzoe D; Frokjaer VG; Holst KK; Christoffersen M; Johansen SS; Svarer C; Madsen J; Rasmussen PM; Ramsøy T; Jernigan TL; Knudsen GM
    Arch Gen Psychiatry; 2011 Jun; 68(6):562-76. PubMed ID: 21646575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907.
    Urban NB; Girgis RR; Talbot PS; Kegeles LS; Xu X; Frankle WG; Hart CL; Slifstein M; Abi-Dargham A; Laruelle M
    Neuropsychopharmacology; 2012 May; 37(6):1465-73. PubMed ID: 22353758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimaging research in human MDMA users: a review.
    Cowan RL
    Psychopharmacology (Berl); 2007 Jan; 189(4):539-56. PubMed ID: 16847678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.
    Kish SJ; Lerch J; Furukawa Y; Tong J; McCluskey T; Wilkins D; Houle S; Meyer J; Mundo E; Wilson AA; Rusjan PM; Saint-Cyr JA; Guttman M; Collins DL; Shapiro C; Warsh JJ; Boileau I
    Brain; 2010 Jun; 133(Pt 6):1779-97. PubMed ID: 20483717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.
    McCann UD; Szabo Z; Vranesic M; Palermo M; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
    Psychopharmacology (Berl); 2008 Oct; 200(3):439-50. PubMed ID: 18661256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain serotonin transporter binding in former users of MDMA ('ecstasy').
    Selvaraj S; Hoshi R; Bhagwagar Z; Murthy NV; Hinz R; Cowen P; Curran HV; Grasby P
    Br J Psychiatry; 2009 Apr; 194(4):355-9. PubMed ID: 19336788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain serotonin synthesis in MDMA (ecstasy) polydrug users: an alpha-[(11) C]methyl-l-tryptophan study.
    Booij L; Soucy JP; Young SN; Regoli M; Gravel P; Diksic M; Leyton M; Pihl RO; Benkelfat C
    J Neurochem; 2014 Dec; 131(5):634-44. PubMed ID: 25041501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study.
    Cowan RL; Lyoo IK; Sung SM; Ahn KH; Kim MJ; Hwang J; Haga E; Vimal RL; Lukas SE; Renshaw PF
    Drug Alcohol Depend; 2003 Dec; 72(3):225-35. PubMed ID: 14643939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acute and chronic effects of MDMA ("ecstasy") on cortical 5-HT2A receptors in rat and human brain.
    Reneman L; Endert E; de Bruin K; Lavalaye J; Feenstra MG; de Wolff FA; Booij J
    Neuropsychopharmacology; 2002 Mar; 26(3):387-96. PubMed ID: 11850153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings.
    Reneman L; Lavalaye J; Schmand B; de Wolff FA; van den Brink W; den Heeten GJ; Booij J
    Arch Gen Psychiatry; 2001 Oct; 58(10):901-6. PubMed ID: 11576026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.
    McCann UD; Szabo Z; Seckin E; Rosenblatt P; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
    Neuropsychopharmacology; 2005 Sep; 30(9):1741-50. PubMed ID: 15841106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.
    Buchert R; Thomasius R; Wilke F; Petersen K; Nebeling B; Obrocki J; Schulze O; Schmidt U; Clausen M
    Am J Psychiatry; 2004 Jul; 161(7):1181-9. PubMed ID: 15229049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MDMA ("Ecstasy") and its association with cerebrovascular accidents: preliminary findings.
    Reneman L; Habraken JB; Majoie CB; Booij J; den Heeten GJ
    AJNR Am J Neuroradiol; 2000; 21(6):1001-7. PubMed ID: 10871002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission.
    Reneman L; Booij J; Schmand B; van den Brink W; Gunning B
    Psychopharmacology (Berl); 2000 Feb; 148(3):322-4. PubMed ID: 10755746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction.
    Quednow BB; Jessen F; Kuhn KU; Maier W; Daum I; Wagner M
    J Psychopharmacol; 2006 May; 20(3):373-84. PubMed ID: 16574711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroimaging in human MDMA (Ecstasy) users.
    Cowan RL; Roberts DM; Joers JM
    Ann N Y Acad Sci; 2008 Oct; 1139():291-8. PubMed ID: 18991874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Ecstasy use is associated with increased cortical excitability: an fMRI study.
    Bauernfeind AL; Dietrich MS; Blackford JU; Charboneau EJ; Lillevig JG; Cannistraci CJ; Woodward ND; Cao A; Watkins T; Di Iorio CR; Cascio C; Salomon RM; Cowan RL
    Neuropsychopharmacology; 2011 May; 36(6):1127-41. PubMed ID: 21326196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memory performance in abstinent 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users.
    Groth-Marnat G; Howchar H; Marsh A
    Percept Mot Skills; 2007 Feb; 104(1):43-55. PubMed ID: 17450963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.